Department of Pharmacy, University of Patras, Greece
Dr. Sophia Hatziantoniou is an accomplished pharmaceutical scientist and Associate Professor at the Department of Pharmacy, University of Patras, specializing in pharmaceutical technology, nanotechnology, topical cosmetics, and advanced drug delivery systems. Her influential investigations in liposomal formulations, nanoemulsions, dendrimer technologies, and anticancer therapeutics have earned wide scientific recognition. With an h-index of 36 and more than 4,400 citations, she has contributed significantly to pharmaceutical nanoscience and biomedical innovation. Her interdisciplinary research integrates nanomedicine, pharmaceutics, and biotechnology to develop novel therapeutic approaches with enhanced clinical effectiveness. Through impactful publications, collaborative projects, and scientific mentorship, Dr. Hatziantoniou continues advancing pharmaceutical sciences while supporting innovative healthcare solutions and translational biomedical research worldwide.
Professional Profile
Education
Dr. Sophia Hatziantoniou developed a strong academic background in pharmaceutical sciences, pharmaceutics, and nanotechnology through advanced higher education and specialized scientific training. Her educational foundation enabled extensive expertise in drug delivery systems, biomaterials, topical formulations, and cancer therapeutics. She cultivated multidisciplinary scientific skills integrating chemistry, biotechnology, pharmaceutical engineering, and biomedical sciences to support innovative healthcare applications. Her academic preparation strengthened her ability to investigate nanoformulations, liposomal carriers, and pharmaceutical nanotechnology for therapeutic improvement. Throughout her scholarly development, she demonstrated dedication to scientific excellence, evidence-based experimentation, and translational pharmaceutical research. Her educational achievements have contributed significantly to her professional growth as a respected academic researcher and mentor in pharmaceutical technology and biomedical innovation.
Professional Experience
Dr. Hatziantoniou has established an impressive professional career as an academic researcher, pharmaceutical scientist, and Associate Professor within the Department of Pharmacy at the University of Patras. She possesses extensive experience in pharmaceutical technology, nanomedicine, topical therapeutics, and anticancer drug delivery systems. Her professional activities include scientific supervision, collaborative biomedical projects, advanced pharmaceutical investigations, and mentoring emerging researchers in nanotechnology-based therapeutics. She has participated in numerous interdisciplinary studies exploring liposomes, nanoemulsions, dendrimers, and controlled-release formulations. Through continuous engagement with international scientific communities, she has contributed to the advancement of pharmaceutics and biomedical innovation. Her long-standing academic and research experience reflects exceptional dedication toward improving therapeutic technologies and healthcare-related scientific progress.
Research Interest
Dr. Sophia Hatziantoniou’s research interests primarily focus on pharmaceutical nanotechnology, advanced drug delivery systems, topical formulations, liposomal therapeutics, and cancer-targeted nanomedicine. Her investigations emphasize nanoformulations designed to improve drug bioavailability, therapeutic effectiveness, controlled release behavior, and biomedical compatibility. She actively explores lipid-based carriers, dendrimer technologies, nanoemulsions, and nanoparticle engineering for pharmaceutical and cosmetic applications. Her scientific work also examines anticancer compounds, curcumin derivatives, vaccine-related pharmaceutical safety, and biomaterial interactions within biological systems. By integrating pharmaceutical sciences with nanotechnology and biotechnology, she contributes to the development of innovative therapeutic platforms with translational healthcare significance. Her interdisciplinary research approach continues advancing pharmaceutical innovation and expanding opportunities in biomedical therapeutics and personalized medicine.
Award and Honor
Dr. Hatziantoniou has earned significant academic recognition for her impactful contributions to pharmaceutical sciences, nanotechnology, and biomedical therapeutics. Her extensive publication record, strong citation performance, and influential scientific collaborations highlight her reputation within international pharmaceutical research communities. She has contributed to highly regarded journals in pharmaceutics, nanomedicine, and biomedical engineering while participating in innovative healthcare research initiatives. Her achievements in liposomal therapeutics, topical pharmaceutical technology, and cancer nanomedicine demonstrate scientific originality and sustained academic excellence. Through collaborative investigations and advanced therapeutic studies, she has gained recognition for promoting translational pharmaceutical innovation and interdisciplinary biomedical progress. Her professional accomplishments reflect dedication to scientific discovery, mentorship, and the advancement of modern pharmaceutical technologies.
Conclusion
Dr. Sophia Hatziantoniou represents an influential figure in pharmaceutical technology and nanomedicine through her impactful scientific achievements, innovative therapeutic investigations, and interdisciplinary collaborations. Her expertise in drug delivery systems, liposomal formulations, and biomedical nanotechnology has contributed substantially to modern pharmaceutical sciences and translational healthcare innovation. With extensive scholarly influence, remarkable citation performance, and internationally recognized research contributions, she continues advancing therapeutic technologies and biomedical understanding. Her commitment to scientific excellence, mentorship, and collaborative healthcare research positions her as a distinguished academic leader with enduring influence on pharmaceutical innovation, nanotherapeutics, and future biomedical developments worldwide.
Publications Top Noted
- Title: Nanoliposomes and their applications in food nanotechnology
Authors: M Reza Mozafari, C Johnson, S Hatziantoniou, C Demetzos
Year: 2008
Citation: 938
Citations: 701
- Title: Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin
Authors: C Tamvakopoulos, K Dimas, ZD Sofianos, S Hatziantoniou, Z Han
Year: 2007
Citation: 238
- Title: A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid
Authors: K Gardikis, S Hatziantoniou, K Viras, M Wagner, C Demetzos
Year: 2006
Citation: 369
- Title: lipid analysis of Greek walnut oil (Juglans regia L.)
Authors: G Tsamouris, S Hatziantoniou, C Demetzos
Year: 2002
Citation: 112
- Title: Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts
Authors: S Hatziantoniou, K Dimas, A Georgopoulos, N Sotiriadou, C Demetzos
Year: 2006
Citation: 94